Page 69 - JCTR-11-1
P. 69

Journal of Clinical and
            Translational Research                                                 Osteoporosis risk factors in diabetics



            setting is 40.89%. The prevalence is higher in females (56.5%)   IEC/AIIMS BBSR/STS/2022-23/09, dated November
            compared to males (26%). The proportion of pre-menopausal   23, 2023) and informed written consent from each study
            women with osteoporosis was found to be 14.2%. A higher   participant.
            proportion of individuals (51.6%) in the 71–80 years’ age
            group had osteoporosis. Anthropometric measurements   Consent for publication
            (BMI and WHR), HbA1C, and serum creatinine displayed   Informed written consent was obtained from the patients
            a significantly positive correlation with T-scores. Age and   who were recruited into the study.
            menopausal duration (in females) exhibited a significantly
            negative correlation with the T-scores; increasing age and   Data availability
            menopausal duration (in females) are potential risk factors   Data prepared from the patients’ medical and laboratory
            for osteoporosis in our study population. Other factors (i.e.,   records are not available publicly. However, on reasonable
            duration of diabetes, serum urea, serum calcium, Vitamin   request, it can be provided.
            D, urine ACR, and TSH levels) do not have any significant
            association with the T-scores. Similar to the normal   References
            population, increasing age and menopause are significant
            risk factors in diabetic individuals as well. Moreover, the   1.   Misra A, Gopalan H, Jayawardena R,  et al. Diabetes in
            10-year fracture probability was significantly high (>3%)   developing countries. J Diabetes. 2019;11(7):522-539.
            in 53 individuals (26.1% of the participants). United      doi: 10.1111/1753-0407.12803
            States (US) Food and Drug Administration-approved   2.   Kanis J. Assessment of Osteoporosis at the Primary Health Care
            medical therapies are recommended in almost 41% of the   Level. Summary Report of a WHO Scientific Group. World
            participants to prevent the formation of fractures. Thus, we   Health Organization Collaborating Centre for Metabolic Bone
            recommend that all patients with T2DM aged 50 years and   Diseases. Report No.: Technical Report. United  Kingdom:
            above, especially females, should be screened for osteopenia   University of Sheffield; 2007. Available from: https://frax.
            and osteoporosis, and offered preventive, therapeutic, and   shef.ac.uk/frax/pdfs/who_technical_report.pdf  [Last
            rehabilitative management.                            accessed on 2024 Sep 01].
                                                               3.   Sözen T, Özışık L, Başaran NÇ. An overview and management
            Acknowledgments                                       of osteoporosis. Eur J Rheumatol. 2017;4(1):46-56.
            The authors are grateful for the support of AIIMS in      doi: 10.5152/eurjrheum.2016.16011
            conducting the investigations for the present study.
                                                               4.   Abushaikha L, Omran S. A survey of osteoporosis risk factors
            Funding                                               and practices among Jordanian women. J Int Womens Stud.
                                                                  2010;11(4):152-161.
            The authors declare that no funds, grants, or other support      doi: 10.1136/jirs.11.4.152
            were received for the conduct of this study or in preparation
            of this manuscript.                                5.   Babhulkar S, Seth S. Prevalence of osteoporosis in India: An
                                                                  observation of 31238 adults. Int J Res Orthop.  2021;7(2):
            Conflict of interest                                  362-368.

            The authors declare that there is no financial or non-     doi: 10.18203/issn.2455-4510
            financial interest in the present study.           6.   Chinese Medical Association.  Guideline for  primary  care
                                                                  of primary osteoporosis (2019). Chin J Gen Pr. 2020;19(4):
            Author contributions                                  304-315.
            Conceptualization: Sujata Devi, Deenadayalan Subhiksha      doi: 10.3760/cma.j.issn.1674-6397.2020.04.001
            Investigation: All authors                         7.   Wongdee K, Charoenphandhu N. Osteoporosis in diabetes
            Writing - original draft: Sujata Devi, Suchanda Sahu,   mellitus: Possible cellular and molecular mechanisms. World
               Deenadayalan Subhiksha                             J Diabetes. 2011;2(3):41-48.
            Writing - review & editing: Kishore Kumar Behera, Nibedita
               Priyadarsini, Anupam Dey, Debananda Sahoo, Arpita      doi: 10.4239/wjd.v2.i3.41
               Dash                                            8.   Adil C, Aydın T, Taşpınar Ö,  et al. Bone mineral density
                                                                  evaluation of patients with type 2 diabetes mellitus. J Phys
            Ethics approval and consent to participate            Ther Sci. 2015;27(1):179-182.

            The present study was conducted after obtaining approval      doi: 10.1589/jpts.27.179
            from the Institution Ethics Committee (approval number:   9.   Xu L, Cheng M, Liu X, Shan P, Gao H. Bone mineral density


            Volume 11 Issue 1 (2025)                        63                            doi: 10.36922/jctr.24.00062
   64   65   66   67   68   69   70   71   72   73   74